Tag: atezolizumab
November 27, 2018
G1 Therapeutics Announces Positive Myelopreservation Data
G1 Therapeutics (Nasdaq:GTHX), a clinical-stage oncology company, today announced positive topline data from its randomized, double-blind, placebo-controlled Phase 2 trial evaluating... September 24, 2018
Genentech’s TECENTRIQ in Combination With Pemetrexed and Platinum-Based Chemotherapy Reduced the Risk of Disease Worsening or Death
Genentech, a member of the Roche Group (SIX:RO,ROG;OTCQX:RHHBY) announced results from the Phase III IMpower132 study of TECENTRIQ (atezolizumab) plus pemetrexed... September 4, 2018